STANFORD, California – Dr. Hank Gardner unveiled HCMS Group’s Human Capital Risk Index® (HUI) for the first time before an academic healthcare conference Sept. 6 at Stanford University.
Gardner outlined the unique features of the HUI metric (patent pending) before more than 100 people attending the Stanford School of Medicine’s Medicine X (MedX) conference, billed as “the intersection of medicine and emerging technologies.” His presentation was part of a session on patient-centered healthcare, one of Gardner’s core tenets as founder, CEO, and principal owner of HCMS.
The HUI individual risk index helps address the central problem in healthcare’s cost and quality problems. It is that 5% of the population accounts for more than 50% of medical spending, and more than half of this group’s expenses are for treatments, diagnostic tests, and medications that aren’t needed or are potentially harmful. HCMS Group’s HUI risk index is the only tool that has been developed to identify people before they enter the 5% high-cost group and steer help to them in managing complex medical situations.
Specifically, Gardner showed how the HUI risk index relies on econometric concepts (rather than actuarial or historical records), provides predictive information (rather than lagging data), and centers on the person (rather than disease). He explained that the index is based on comprehensive data including medical, pharmacy, and lost time, and relies on more than 300 weighted risk variables. (To view the presentation, click here.)
Members of the standing-room audience took notes on laptops, photographed Gardner’s slides and sent several tweets quoting his comments. Charles Ornstein, a Pulitzer Prize-winning investigative healthcare reporter with ProPublica who was a keynote speaker at the conference, posted this on Twitter: “The medical system is very good at piling on when you show up with a specific disease,” says Hank Gardner of HCMS Group. The HUI risk index dominated questions after the session.